These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6639832)

  • 1. Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine.
    Quattrone A; Tedeschi G; Aguglia U; Scopacasa F; Direnzo GF; Annunziato L
    Br J Clin Pharmacol; 1983 Nov; 16(5):471-5. PubMed ID: 6639832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonergic regulation of prolactin and growth hormone secretion in man.
    Lewis DA; Sherman BM
    Acta Endocrinol (Copenh); 1985 Oct; 110(2):152-7. PubMed ID: 4060968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does metergoline selectively attenuate 5-HT mediated prolactin release?
    Ellis PM; Gartside SE; Ware CJ; Campling GM; Cowen PJ
    Psychopharmacology (Berl); 1991; 105(1):129-31. PubMed ID: 1745704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pindolol on the prolactin response to d-fenfluramine.
    Park SB; Cowen PJ
    Psychopharmacology (Berl); 1995 Apr; 118(4):471-4. PubMed ID: 7568634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depending on the stimulus, central serotoninergic activation by fenfluramine blocks or does not alter growth hormone secretion in man.
    Casanueva FF; Villanueva L; Peñalva A; Cabezas-Cerrato J
    Neuroendocrinology; 1984 Apr; 38(4):302-8. PubMed ID: 6374488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naloxone reduces the fenfluramine-induced prolactin release in man.
    Foresta C; Scanelli G; Indino M; Federspil G; Scandellari C
    Clin Endocrinol (Oxf); 1985 Apr; 22(4):539-43. PubMed ID: 3987071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of 5-HT 1 serotonin receptors in the medial basal hypothalamus stimulates prolactin secretion in the unanaesthetized rat.
    Willoughby JO; Menadue MF; Liebelt HJ
    Neuroendocrinology; 1988 Jan; 47(1):83-7. PubMed ID: 3340274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sleep suppressant action of fenfluramine in rats. I. Relation to postsynaptic serotonergic stimulation.
    Fornal C; Radulovacki M
    J Pharmacol Exp Ther; 1983 Jun; 225(3):667-74. PubMed ID: 6683311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of midbrain raphe lesion or 5,7-dihydroxytryptamine treatment on the prolactin-releasing action of quipazine and D-fenfluramine in rats.
    Quattrone A; Schettini G; di Renzo G; Tedeschi G; Preziosi P
    Brain Res; 1979 Sep; 174(1):71-9. PubMed ID: 487124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lithium on the prolactin response to D-fenfluramine in healthy subjects.
    Power AC; Dorkins CE; Cowen PJ
    Biol Psychiatry; 1993 Jun 1-15; 33(11-12):801-5. PubMed ID: 8373918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of gonadal steroids in the serotoninergic control of prolactin secretion in men.
    Foresta C; Indino M; Scandellari C
    Clin Endocrinol (Oxf); 1987 May; 26(5):601-7. PubMed ID: 3665121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma prolactin levels induced in rats by d-fenfluramine: relation to central serotonergic stimulation.
    Quattrone A; Di Renzo G; Schettini G; Tedeschi G; Scopacasa F
    Eur J Pharmacol; 1978 May; 49(2):163-7. PubMed ID: 149011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for 5-hydroxytryptamine1A receptor involvement in the control of prolactin secretion in man.
    Palazidou E; Stephenson J; Butler J; Coskeran P; Chambers S; McGregor AM
    Psychopharmacology (Berl); 1995 Jun; 119(3):311-4. PubMed ID: 7675967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the mode of the prolactin release-inhibiting action of the serotonin receptor blockers metergoline, methysergide, and cyproheptadine.
    Krulich L; McCann SM; Mayfield MA
    Endocrinology; 1981 Apr; 108(4):1115-24. PubMed ID: 7472261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is receptor activation involved in the mechanism by which (+)-fenfluramine and (+)-norfenfluramine deplete 5-hydroxytryptamine in the rat brain?
    Invernizzi R; Kmieciak-Kolada K; Samanin R
    Br J Pharmacol; 1982 Mar; 75(3):525-30. PubMed ID: 6175368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fenfluramine on prolactin secretion in obese patients: evidence for serotoninergic regulation of prolactin in man.
    Barbieri C; Magnoni V; Rauhe WG; Zanasi S; Caldara R; Ferrari C
    Clin Endocrinol (Oxf); 1983 Dec; 19(6):705-10. PubMed ID: 6360431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyper- and hyposensitivity of central serotonin receptors:[3H]serotonin binding and functional studies in the rat.
    Samanin R; Mennini T; Ferraris A; Bendotti C; Borsini F
    Brain Res; 1980 May; 189(2):449-57. PubMed ID: 7189434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeated treatment with d-fenfluramine or metergoline alters cortex binding of 3H-serotonin and serotenergic sensitivity in rats.
    Samanin R; Mennini T; Ferraris A; Bendotti C; Borsini F
    Eur J Pharmacol; 1980 Jan; 61(2):203-6. PubMed ID: 7353591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dieting decreases plasma tryptophan and increases the prolactin response to d-fenfluramine in women but not men.
    Walsh AE; Oldman AD; Franklin M; Fairburn CG; Cowen PJ
    J Affect Disord; 1995 Feb; 33(2):89-97. PubMed ID: 7759666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain 5-HT function in obsessive-compulsive disorder. Prolactin responses to d-fenfluramine.
    Fineberg NA; Roberts A; Montgomery SA; Cowen PJ
    Br J Psychiatry; 1997 Sep; 171():280-2. PubMed ID: 9337985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.